SEC Company Response from vTv Therapeutics Inc. (VTVT) (CIK 0001641489) (VTVT) — Apr 25, 2024
vTv Therapeutics Inc. (VTVT) (CIK 0001641489)
Date: April 25, 2024 · CIK: 0001641489 · Accession: 0001193125-24-114526
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278612
Letter
Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission Attention: Re: vTv Therapeutics Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-278612
Dear Mr. Crawford,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), vTv Therapeutics Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to April 29, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616.
If you have any questions regarding this request, please contact David Rosenthal of Dechert LLP at (212) 698-3616.
Sincerely,
VTV THERAPEUTICS INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 25, 2024 Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford Re: vTv Therapeutics Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-278612 Dear Mr. Crawford, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), vTv Therapeutics Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to April 29, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616. If you have any questions regarding this request, please contact David Rosenthal of Dechert LLP at (212) 698-3616. Sincerely, VTV THERAPEUTICS INC. /s/ Steven Tuch Steven Tuch Chief Financial Officer cc: David S. Rosenthal, Dechert LLP